In both CCl4-induced and MCD diet-induced liver fibrosis models, BMSC-EVs suppressed intrahepatic B cell activity by modulating the MAPK and NF-κB signaling pathways, reducing inflammation and fibrogenesis. This evidence concerns the gene NFKB1 and Hepatic fibrosis.